Indapamida Pharmakern (Indapamide)

Indapamide inhibits the sodium‑chloride cotransporter in the distal convoluted tubule of the kidney, decreasing reabsorption of these ions. The resulting loss of sodium and water produces a diuretic effect, while modest vasodilation lowers peripheral vascular resistance, together helping to control blood pressure.

The appropriate dose of indapamide is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and renal function. Dosage may vary, and patients should follow the specific instructions provided by their healthcare professional.

Safety data for indapamide in pregnancy and lactation are limited. It is generally classified as contraindicated or to be used only if the potential benefit justifies the potential risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their doctor.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Indapamide shares the thiazide‑like mechanism of hydrochlorothiazide but often provides a longer duration of action and may have a more favorable metabolic profile, with less impact on glucose and lipid levels. Both lower blood pressure, yet individual response and tolerability can differ, so clinicians choose based on patient‑specific factors.

Store the tablets at room temperature, below 25 °C, in the original packaging. Keep the container tightly closed, protect it from moisture, heat and direct sunlight to maintain product stability throughout its shelf life.

Indapamida Pharmakern is taken orally, usually with a glass of water. It may be taken with or without food, as directed by the prescriber. Patients should swallow the tablet whole and not crush or chew it unless specifically instructed.

Serious risks include severe dehydration, significant electrolyte disturbances such as low potassium or sodium, acute kidney injury, and rare allergic reactions like rash or angioedema. Patients should seek medical attention promptly if they experience symptoms such as rapid weight loss, muscle weakness, severe dizziness, or swelling of the face and throat.

Indapamide is contraindicated in patients with known hypersensitivity to the drug, severe renal or hepatic impairment, and in those with anuria. Caution is also advised for individuals with gout, uncontrolled diabetes, or those taking medications that may cause dangerous electrolyte shifts. A healthcare professional should evaluate suitability before initiating therapy.